Evidence map›Paper›PMID 35148177›Full record

ArticleScience advances2022

Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis.

Jing He, Yanan Chu, Jing Li, Qingren Meng, Yudong Liu, Jiayang Jin, Yifan Wang, Jian Wang, Bo Huang, Lianjie Shi and 14 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 2 pooled it
31.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 2 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Gut microbes · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Intestinal-Bone Axis Mediated byMicroorganisms · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. [Gut-brain-joint axis in rheumatoid arthritis: from microeco-logical disturbance to multi-target synergy].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  18. Review
  19. The gut-joint axis in juvenile idiopathic arthritis.Arthritis research & therapy · 2026
    Review
  20. Review

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 1 country.

Jing HeDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0003-3904-8928
Yanan ChuCAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformatics, Beijing 100101, China.ORCID 0000-0002-9349-4307
Jing LiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0002-6385-8958
Qingren MengSchool of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0002-4842-7527
Yudong LiuDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0002-5153-3400
Jiayang JinDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Yifan WangDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0001-7056-6251
Jian WangCAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformatics, Beijing 100101, China.
Bo HuangDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0001-7811-898X
Lianjie ShiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Xing ShiDepartment of Respiratory and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0003-2778-5373
Jiayi TianDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Yunzhi ZhufengDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0002-8485-9845
Ruiling FengDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0003-1465-3259
Wenjing XiaoDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Yuzhou GanDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Jianping GuoDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0002-5031-3510
Changjun ShaoCAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformatics, Beijing 100101, China.
Yin SuDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Fanlei HuDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0002-3892-3164
Xiaolin SunDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Jun YuUniversity of Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0001-7599-2700
Yu KangCAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformatics, Beijing 100101, China.ORCID 0000-0001-5196-0376
Zhanguo LiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0002-2590-6242
Peking University · CNBeijing Institute of Genomics · CNSouthern University of Science and Technology · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The imbalance between pathogenic and beneficial species of the intestinal microbiome and metabolism in rheumatoid arthritis (RA) remains unclarified. Here, using shotgun-based metagenome sequencing for a treatment-naïve patient cohort and a "quasi-paired cohort" method, we observed a deficiency of butyrate-producing species and an overwhelming number of butyrate consumers in RA patients. These outcomes mainly occurred in patients with positive ACPA, with a mean AUC of 0.94. This panel was also validated in established RA with an AUC of 0.986 in those with joint deformity. In addition, we showed that butyrate promoted T

Indexed as

Arthritis, RheumatoidGastrointestinal MicrobiomeAnimalsAnti-Inflammatory AgentsButyratesHumansMiceT-Lymphocytes, RegulatoryAnti-Inflammatory AgentsButyrates

Identifiers

PMID35148177
PMCPMC11093108
OpenAlexW4211229201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.